Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Relapsed/Refractory Multiple Myeloma (United States and Western Europe, Japan, Singapore, Canada and Brazil)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Aplastic Anemia - Patient Education and Support (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates
    Enhance Clinical Research Capacity and Capability in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Optimizing Telemedicine/Telehealth for the Rheumatology Community
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Quality of Care Initiative to Improve the Treatment of Locally Advanced or Metastatic (Stage IV) Bladder Cancer Patients
    Release Date:
    Partner: National Comprehensive Cancer Network, EMD Serono
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease by a Multidisciplinary Team
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease All
    Improving NOAC adherence and persistence, initiatives for pharmacists
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Israel
    Review and Analysis of Retrospective, Local Source, Serotype Distribution for Invasive Pneumococcal Disease in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Invasive Fungal Infections Research in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Addressing Knowledge Gaps in Inflammatory Bowel Disease (IBD) Care
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA